T . T .
. . .
T . 21.
. 21. T 2 2 .
T .
12 .
T .
T . .
T TT T . 21.
TELOMERE LENGTH IN PD
. investigated telomere length and different markers of oxidative stress in patients suffering from PD 211.
T .
THE ORIGINAL INTERNIST 21 T
T . T . . . T . 211.
COQ-10 DEFICIENCY AND PD
. investigate . T 212.1
2 2. . T 1 . 2 .
T 1 . T .. 1 .
T 1 212.2
. investigated whether a combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s diseases (HD) 2. 1
2
22
. T T . 2 1 . T . . 211.
T
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52